nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—Carcinoma breast—Spironolactone—dilated cardiomyopathy	0.0827	0.104	CcSEcCtD
Zolmitriptan—Breast cancer—Spironolactone—dilated cardiomyopathy	0.0307	0.0385	CcSEcCtD
Zolmitriptan—Tetany—Furosemide—dilated cardiomyopathy	0.0187	0.0235	CcSEcCtD
Zolmitriptan—Infarction—Lisinopril—dilated cardiomyopathy	0.0165	0.0207	CcSEcCtD
Zolmitriptan—Pyelonephritis—Lisinopril—dilated cardiomyopathy	0.012	0.0151	CcSEcCtD
Zolmitriptan—Ulcer—Spironolactone—dilated cardiomyopathy	0.0118	0.0149	CcSEcCtD
Zolmitriptan—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.0103	0.0129	CcSEcCtD
Zolmitriptan—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.00945	0.0119	CcSEcCtD
Zolmitriptan—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.00905	0.0114	CcSEcCtD
Zolmitriptan—Renal pain—Lisinopril—dilated cardiomyopathy	0.00869	0.0109	CcSEcCtD
Zolmitriptan—Apathy—Furosemide—dilated cardiomyopathy	0.00853	0.0107	CcSEcCtD
Zolmitriptan—Flat affect—Furosemide—dilated cardiomyopathy	0.00845	0.0106	CcSEcCtD
Zolmitriptan—Ataxia—Spironolactone—dilated cardiomyopathy	0.00764	0.0096	CcSEcCtD
Zolmitriptan—Gastritis—Spironolactone—dilated cardiomyopathy	0.00719	0.00903	CcSEcCtD
Zolmitriptan—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.00712	0.00894	CcSEcCtD
Zolmitriptan—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00695	0.00873	CcSEcCtD
Zolmitriptan—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00634	0.00796	CcSEcCtD
Zolmitriptan—Throat sore—Lisinopril—dilated cardiomyopathy	0.00634	0.00796	CcSEcCtD
Zolmitriptan—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00628	0.00789	CcSEcCtD
Zolmitriptan—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00597	0.00749	CcSEcCtD
Zolmitriptan—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00559	0.00703	CcSEcCtD
Zolmitriptan—Urine output increased—Furosemide—dilated cardiomyopathy	0.00551	0.00692	CcSEcCtD
Zolmitriptan—Bladder pain—Furosemide—dilated cardiomyopathy	0.00551	0.00692	CcSEcCtD
Zolmitriptan—Mental disability—Furosemide—dilated cardiomyopathy	0.00528	0.00664	CcSEcCtD
Zolmitriptan—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00516	0.00649	CcSEcCtD
Zolmitriptan—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00511	0.00641	CcSEcCtD
Zolmitriptan—Polyuria—Furosemide—dilated cardiomyopathy	0.00503	0.00632	CcSEcCtD
Zolmitriptan—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00503	0.00632	CcSEcCtD
Zolmitriptan—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00502	0.00631	CcSEcCtD
Zolmitriptan—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00502	0.00631	CcSEcCtD
Zolmitriptan—Cough increased—Lisinopril—dilated cardiomyopathy	0.00499	0.00627	CcSEcCtD
Zolmitriptan—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0047	0.00591	CcSEcCtD
Zolmitriptan—Thirst—Furosemide—dilated cardiomyopathy	0.00465	0.00583	CcSEcCtD
Zolmitriptan—Neck pain—Lisinopril—dilated cardiomyopathy	0.00462	0.00581	CcSEcCtD
Zolmitriptan—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00457	0.00574	CcSEcCtD
Zolmitriptan—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00457	0.00574	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00454	0.0057	CcSEcCtD
Zolmitriptan—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00446	0.00561	CcSEcCtD
Zolmitriptan—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00444	0.00557	CcSEcCtD
Zolmitriptan—Malaise—Spironolactone—dilated cardiomyopathy	0.00441	0.00554	CcSEcCtD
Zolmitriptan—Cystitis—Lisinopril—dilated cardiomyopathy	0.00441	0.00554	CcSEcCtD
Zolmitriptan—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00438	0.0055	CcSEcCtD
Zolmitriptan—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00429	0.00539	CcSEcCtD
Zolmitriptan—Photophobia—Lisinopril—dilated cardiomyopathy	0.00429	0.00539	CcSEcCtD
Zolmitriptan—Irritability—Furosemide—dilated cardiomyopathy	0.00422	0.0053	CcSEcCtD
Zolmitriptan—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00413	0.00519	CcSEcCtD
Zolmitriptan—Discomfort—Spironolactone—dilated cardiomyopathy	0.00412	0.00517	CcSEcCtD
Zolmitriptan—Dehydration—Furosemide—dilated cardiomyopathy	0.00411	0.00516	CcSEcCtD
Zolmitriptan—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00407	0.00511	CcSEcCtD
Zolmitriptan—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00404	0.00507	CcSEcCtD
Zolmitriptan—Confusional state—Spironolactone—dilated cardiomyopathy	0.00403	0.00506	CcSEcCtD
Zolmitriptan—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00401	0.00503	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00399	0.00502	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00391	0.00491	CcSEcCtD
Zolmitriptan—Muscular weakness—Furosemide—dilated cardiomyopathy	0.0039	0.0049	CcSEcCtD
Zolmitriptan—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00378	0.00475	CcSEcCtD
Zolmitriptan—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00378	0.00474	CcSEcCtD
Zolmitriptan—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00375	0.00471	CcSEcCtD
Zolmitriptan—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00374	0.0047	CcSEcCtD
Zolmitriptan—Eczema—Lisinopril—dilated cardiomyopathy	0.00369	0.00464	CcSEcCtD
Zolmitriptan—Somnolence—Spironolactone—dilated cardiomyopathy	0.00355	0.00446	CcSEcCtD
Zolmitriptan—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00353	0.00443	CcSEcCtD
Zolmitriptan—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.0035	0.0044	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00349	0.00438	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00345	0.00433	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00345	0.00433	CcSEcCtD
Zolmitriptan—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00343	0.0043	CcSEcCtD
Zolmitriptan—Arthritis—Lisinopril—dilated cardiomyopathy	0.00341	0.00429	CcSEcCtD
Zolmitriptan—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00332	0.00417	CcSEcCtD
Zolmitriptan—Diplopia—Lisinopril—dilated cardiomyopathy	0.00332	0.00417	CcSEcCtD
Zolmitriptan—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00329	0.00413	CcSEcCtD
Zolmitriptan—Sweating—Furosemide—dilated cardiomyopathy	0.00327	0.0041	CcSEcCtD
Zolmitriptan—Face oedema—Lisinopril—dilated cardiomyopathy	0.0032	0.00402	CcSEcCtD
Zolmitriptan—Urticaria—Spironolactone—dilated cardiomyopathy	0.00317	0.00399	CcSEcCtD
Zolmitriptan—Irritability—Lisinopril—dilated cardiomyopathy	0.00317	0.00398	CcSEcCtD
Zolmitriptan—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00316	0.00397	CcSEcCtD
Zolmitriptan—Ataxia—Lisinopril—dilated cardiomyopathy	0.00312	0.00392	CcSEcCtD
Zolmitriptan—Dehydration—Lisinopril—dilated cardiomyopathy	0.00308	0.00387	CcSEcCtD
Zolmitriptan—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00303	0.00381	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00302	0.00379	CcSEcCtD
Zolmitriptan—Urethral disorder—Furosemide—dilated cardiomyopathy	0.003	0.00377	CcSEcCtD
Zolmitriptan—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00294	0.0037	CcSEcCtD
Zolmitriptan—Gastritis—Lisinopril—dilated cardiomyopathy	0.00294	0.00369	CcSEcCtD
Zolmitriptan—Influenza—Lisinopril—dilated cardiomyopathy	0.00287	0.0036	CcSEcCtD
Zolmitriptan—Tinnitus—Furosemide—dilated cardiomyopathy	0.00285	0.00358	CcSEcCtD
Zolmitriptan—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00284	0.00357	CcSEcCtD
Zolmitriptan—Pruritus—Spironolactone—dilated cardiomyopathy	0.00283	0.00355	CcSEcCtD
Zolmitriptan—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00282	0.00354	CcSEcCtD
Zolmitriptan—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00281	0.00353	CcSEcCtD
Zolmitriptan—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00279	0.00351	CcSEcCtD
Zolmitriptan—Angiopathy—Furosemide—dilated cardiomyopathy	0.00277	0.00349	CcSEcCtD
Zolmitriptan—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00276	0.00347	CcSEcCtD
Zolmitriptan—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00276	0.00346	CcSEcCtD
Zolmitriptan—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00273	0.00343	CcSEcCtD
Zolmitriptan—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00273	0.00343	CcSEcCtD
Zolmitriptan—Erythema—Furosemide—dilated cardiomyopathy	0.00266	0.00334	CcSEcCtD
Zolmitriptan—Dizziness—Spironolactone—dilated cardiomyopathy	0.00264	0.00332	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00262	0.00329	CcSEcCtD
Zolmitriptan—Weight increased—Lisinopril—dilated cardiomyopathy	0.00261	0.00328	CcSEcCtD
Zolmitriptan—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00261	0.00327	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00259	0.00325	CcSEcCtD
Zolmitriptan—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00257	0.00323	CcSEcCtD
Zolmitriptan—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00256	0.00322	CcSEcCtD
Zolmitriptan—Vomiting—Spironolactone—dilated cardiomyopathy	0.00254	0.00319	CcSEcCtD
Zolmitriptan—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00252	0.00317	CcSEcCtD
Zolmitriptan—Rash—Spironolactone—dilated cardiomyopathy	0.00252	0.00316	CcSEcCtD
Zolmitriptan—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00252	0.00316	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00251	0.00315	CcSEcCtD
Zolmitriptan—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00251	0.00315	CcSEcCtD
Zolmitriptan—Headache—Spironolactone—dilated cardiomyopathy	0.0025	0.00314	CcSEcCtD
Zolmitriptan—Jaundice—Lisinopril—dilated cardiomyopathy	0.00249	0.00313	CcSEcCtD
Zolmitriptan—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00248	0.00312	CcSEcCtD
Zolmitriptan—Sweating—Lisinopril—dilated cardiomyopathy	0.00245	0.00308	CcSEcCtD
Zolmitriptan—Agitation—Furosemide—dilated cardiomyopathy	0.00245	0.00307	CcSEcCtD
Zolmitriptan—Haematuria—Lisinopril—dilated cardiomyopathy	0.00244	0.00306	CcSEcCtD
Zolmitriptan—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00241	0.00303	CcSEcCtD
Zolmitriptan—Sinusitis—Lisinopril—dilated cardiomyopathy	0.0024	0.00301	CcSEcCtD
Zolmitriptan—Vertigo—Furosemide—dilated cardiomyopathy	0.00239	0.003	CcSEcCtD
Zolmitriptan—Leukopenia—Furosemide—dilated cardiomyopathy	0.00238	0.00299	CcSEcCtD
Zolmitriptan—Nausea—Spironolactone—dilated cardiomyopathy	0.00237	0.00298	CcSEcCtD
Zolmitriptan—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00234	0.00293	CcSEcCtD
Zolmitriptan—Rhinitis—Lisinopril—dilated cardiomyopathy	0.0023	0.00289	CcSEcCtD
Zolmitriptan—Hallucination—Lisinopril—dilated cardiomyopathy	0.00228	0.00287	CcSEcCtD
Zolmitriptan—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00228	0.00286	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00227	0.00285	CcSEcCtD
Zolmitriptan—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00226	0.00284	CcSEcCtD
Zolmitriptan—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00225	0.00283	CcSEcCtD
Zolmitriptan—Dry mouth—Furosemide—dilated cardiomyopathy	0.00222	0.00278	CcSEcCtD
Zolmitriptan—Confusional state—Furosemide—dilated cardiomyopathy	0.00219	0.00275	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00217	0.00273	CcSEcCtD
Zolmitriptan—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00214	0.00269	CcSEcCtD
Zolmitriptan—Shock—Furosemide—dilated cardiomyopathy	0.00214	0.00269	CcSEcCtD
Zolmitriptan—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00213	0.00268	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00213	0.00267	CcSEcCtD
Zolmitriptan—Skin disorder—Furosemide—dilated cardiomyopathy	0.00211	0.00265	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.0021	0.00264	CcSEcCtD
Zolmitriptan—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00208	0.00262	CcSEcCtD
Zolmitriptan—Anorexia—Furosemide—dilated cardiomyopathy	0.00207	0.0026	CcSEcCtD
Zolmitriptan—Chills—Lisinopril—dilated cardiomyopathy	0.00206	0.00259	CcSEcCtD
Zolmitriptan—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00205	0.00257	CcSEcCtD
Zolmitriptan—Erythema—Lisinopril—dilated cardiomyopathy	0.002	0.00251	CcSEcCtD
Zolmitriptan—Tension—Lisinopril—dilated cardiomyopathy	0.00196	0.00246	CcSEcCtD
Zolmitriptan—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00196	0.00246	CcSEcCtD
Zolmitriptan—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00195	0.00245	CcSEcCtD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00194	0.00952	CbGpPWpGaD
Zolmitriptan—Nervousness—Lisinopril—dilated cardiomyopathy	0.00194	0.00244	CcSEcCtD
Zolmitriptan—Back pain—Lisinopril—dilated cardiomyopathy	0.00193	0.00243	CcSEcCtD
Zolmitriptan—Somnolence—Furosemide—dilated cardiomyopathy	0.00193	0.00243	CcSEcCtD
Zolmitriptan—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00192	0.00241	CcSEcCtD
Zolmitriptan—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00189	0.00237	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00188	0.00236	CcSEcCtD
Zolmitriptan—Tremor—Lisinopril—dilated cardiomyopathy	0.00187	0.00235	CcSEcCtD
Zolmitriptan—Constipation—Furosemide—dilated cardiomyopathy	0.00186	0.00233	CcSEcCtD
Zolmitriptan—Pain—Furosemide—dilated cardiomyopathy	0.00186	0.00233	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00185	0.00233	CcSEcCtD
Zolmitriptan—Angioedema—Lisinopril—dilated cardiomyopathy	0.00183	0.00229	CcSEcCtD
Zolmitriptan—Malaise—Lisinopril—dilated cardiomyopathy	0.0018	0.00226	CcSEcCtD
Zolmitriptan—Vertigo—Lisinopril—dilated cardiomyopathy	0.00179	0.00225	CcSEcCtD
Zolmitriptan—Syncope—Lisinopril—dilated cardiomyopathy	0.00179	0.00225	CcSEcCtD
Zolmitriptan—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00179	0.00225	CcSEcCtD
Zolmitriptan—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00179	0.00225	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00178	0.00223	CcSEcCtD
Zolmitriptan—Palpitations—Lisinopril—dilated cardiomyopathy	0.00177	0.00222	CcSEcCtD
Zolmitriptan—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00176	0.00221	CcSEcCtD
Zolmitriptan—Cough—Lisinopril—dilated cardiomyopathy	0.00174	0.00219	CcSEcCtD
Zolmitriptan—Urticaria—Furosemide—dilated cardiomyopathy	0.00173	0.00217	CcSEcCtD
Zolmitriptan—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00172	0.00216	CcSEcCtD
Zolmitriptan—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00172	0.00216	CcSEcCtD
Zolmitriptan—Myalgia—Lisinopril—dilated cardiomyopathy	0.0017	0.00214	CcSEcCtD
Zolmitriptan—Arthralgia—Lisinopril—dilated cardiomyopathy	0.0017	0.00214	CcSEcCtD
Zolmitriptan—Chest pain—Lisinopril—dilated cardiomyopathy	0.0017	0.00214	CcSEcCtD
Zolmitriptan—Anxiety—Lisinopril—dilated cardiomyopathy	0.00169	0.00213	CcSEcCtD
Zolmitriptan—Discomfort—Lisinopril—dilated cardiomyopathy	0.00168	0.00211	CcSEcCtD
Zolmitriptan—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00166	0.00209	CcSEcCtD
Zolmitriptan—Confusional state—Lisinopril—dilated cardiomyopathy	0.00164	0.00206	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00163	0.00205	CcSEcCtD
Zolmitriptan—Oedema—Lisinopril—dilated cardiomyopathy	0.00163	0.00205	CcSEcCtD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00162	0.00796	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00162	0.00796	CbGpPWpGaD
Zolmitriptan—Infection—Lisinopril—dilated cardiomyopathy	0.00162	0.00203	CcSEcCtD
Zolmitriptan—Shock—Lisinopril—dilated cardiomyopathy	0.0016	0.00201	CcSEcCtD
Zolmitriptan—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.0016	0.00201	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.0016	0.002	CcSEcCtD
Zolmitriptan—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00159	0.002	CcSEcCtD
Zolmitriptan—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00158	0.00199	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00158	0.00198	CcSEcCtD
Zolmitriptan—Asthenia—Furosemide—dilated cardiomyopathy	0.00156	0.00196	CcSEcCtD
Zolmitriptan—Anorexia—Lisinopril—dilated cardiomyopathy	0.00155	0.00195	CcSEcCtD
Zolmitriptan—HTR1F—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00154	0.00755	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00154	0.00755	CbGpPWpGaD
Zolmitriptan—Pruritus—Furosemide—dilated cardiomyopathy	0.00154	0.00193	CcSEcCtD
Zolmitriptan—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00153	0.0075	CbGpPWpGaD
Zolmitriptan—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00149	0.00187	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00149	0.00187	CcSEcCtD
Zolmitriptan—Insomnia—Lisinopril—dilated cardiomyopathy	0.00147	0.00185	CcSEcCtD
Zolmitriptan—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00146	0.00184	CcSEcCtD
Zolmitriptan—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00145	0.00183	CcSEcCtD
Zolmitriptan—Somnolence—Lisinopril—dilated cardiomyopathy	0.00145	0.00182	CcSEcCtD
Zolmitriptan—Dizziness—Furosemide—dilated cardiomyopathy	0.00144	0.0018	CcSEcCtD
Zolmitriptan—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00144	0.0018	CcSEcCtD
Zolmitriptan—HTR1F—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00143	0.00702	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00143	0.00701	CbGpPWpGaD
Zolmitriptan—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00142	0.00178	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00141	0.00177	CcSEcCtD
Zolmitriptan—Pain—Lisinopril—dilated cardiomyopathy	0.00139	0.00175	CcSEcCtD
Zolmitriptan—Constipation—Lisinopril—dilated cardiomyopathy	0.00139	0.00175	CcSEcCtD
Zolmitriptan—Vomiting—Furosemide—dilated cardiomyopathy	0.00138	0.00174	CcSEcCtD
Zolmitriptan—Rash—Furosemide—dilated cardiomyopathy	0.00137	0.00172	CcSEcCtD
Zolmitriptan—Dermatitis—Furosemide—dilated cardiomyopathy	0.00137	0.00172	CcSEcCtD
Zolmitriptan—Headache—Furosemide—dilated cardiomyopathy	0.00136	0.00171	CcSEcCtD
Zolmitriptan—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00134	0.00169	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00133	0.00167	CcSEcCtD
Zolmitriptan—HTR1F—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00133	0.00651	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—ABCC9—dilated cardiomyopathy	0.0013	0.00636	CbGpPWpGaD
Zolmitriptan—Urticaria—Lisinopril—dilated cardiomyopathy	0.0013	0.00163	CcSEcCtD
Zolmitriptan—Nausea—Furosemide—dilated cardiomyopathy	0.00129	0.00162	CcSEcCtD
Zolmitriptan—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00129	0.00162	CcSEcCtD
Zolmitriptan—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00129	0.00162	CcSEcCtD
Zolmitriptan—HTR1F—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00129	0.00631	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—ACTN2—dilated cardiomyopathy	0.00124	0.0061	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00122	0.006	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00122	0.006	CbGpPWpGaD
Zolmitriptan—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.0012	0.00151	CcSEcCtD
Zolmitriptan—Asthenia—Lisinopril—dilated cardiomyopathy	0.00117	0.00147	CcSEcCtD
Zolmitriptan—Pruritus—Lisinopril—dilated cardiomyopathy	0.00115	0.00145	CcSEcCtD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00114	0.00558	CbGpPWpGaD
Zolmitriptan—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00112	0.0014	CcSEcCtD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.0011	0.00541	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.0011	0.00539	CbGpPWpGaD
Zolmitriptan—Dizziness—Lisinopril—dilated cardiomyopathy	0.00108	0.00135	CcSEcCtD
Zolmitriptan—HTR1F—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00104	0.00511	CbGpPWpGaD
Zolmitriptan—Vomiting—Lisinopril—dilated cardiomyopathy	0.00104	0.0013	CcSEcCtD
Zolmitriptan—Rash—Lisinopril—dilated cardiomyopathy	0.00103	0.00129	CcSEcCtD
Zolmitriptan—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00103	0.00129	CcSEcCtD
Zolmitriptan—Headache—Lisinopril—dilated cardiomyopathy	0.00102	0.00128	CcSEcCtD
Zolmitriptan—HTR1D—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000985	0.00483	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000985	0.00483	CbGpPWpGaD
Zolmitriptan—Nausea—Lisinopril—dilated cardiomyopathy	0.000968	0.00122	CcSEcCtD
Zolmitriptan—HTR1B—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000964	0.00473	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000964	0.00473	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000941	0.00462	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000932	0.00457	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000932	0.00457	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000915	0.00449	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000914	0.00448	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000896	0.0044	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000895	0.00439	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000893	0.00438	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000891	0.00437	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000867	0.00425	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00085	0.00417	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000839	0.00412	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000833	0.00409	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000832	0.00408	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000823	0.00403	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000806	0.00395	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000783	0.00384	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000783	0.00384	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000773	0.00379	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000767	0.00376	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000767	0.00376	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000758	0.00372	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000734	0.0036	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000734	0.0036	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000728	0.00357	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000717	0.00352	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000713	0.0035	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000706	0.00346	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000705	0.00346	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000703	0.00345	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00069	0.00338	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000688	0.00337	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000683	0.00335	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000682	0.00334	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00068	0.00334	CbGpPWpGaD
Zolmitriptan—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000678	0.00333	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000667	0.00327	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000662	0.00325	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000657	0.00322	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000653	0.0032	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000634	0.00311	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000614	0.00301	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000602	0.00295	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000596	0.00292	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000596	0.00292	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000589	0.00289	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000584	0.00286	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000584	0.00286	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000584	0.00286	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000584	0.00286	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000571	0.0028	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000559	0.00274	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000554	0.00272	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000543	0.00266	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000543	0.00266	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000537	0.00263	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000533	0.00261	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000527	0.00258	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000527	0.00258	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000526	0.00258	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000526	0.00258	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000524	0.00257	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000522	0.00256	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ANKRD1—dilated cardiomyopathy	0.000507	0.00249	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000504	0.00247	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000497	0.00244	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00049	0.0024	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000478	0.00235	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000478	0.00235	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—TAZ—dilated cardiomyopathy	0.000476	0.00234	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000474	0.00233	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000458	0.00225	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000449	0.0022	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000449	0.0022	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000445	0.00218	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000445	0.00218	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000445	0.00218	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000441	0.00216	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000435	0.00213	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—SDHA—dilated cardiomyopathy	0.000431	0.00211	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000431	0.00211	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000426	0.00209	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000426	0.00209	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000424	0.00208	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00042	0.00206	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000415	0.00203	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000413	0.00203	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000405	0.00199	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0004	0.00196	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000397	0.00195	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000395	0.00193	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000384	0.00188	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000369	0.00181	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000368	0.0018	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000349	0.00171	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000342	0.00168	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000337	0.00165	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000337	0.00165	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00033	0.00162	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00033	0.00162	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000324	0.00159	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000323	0.00158	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000318	0.00156	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000316	0.00155	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000316	0.00155	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000313	0.00154	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000307	0.0015	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000306	0.0015	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000306	0.0015	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000303	0.00149	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000303	0.00148	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000303	0.00148	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.0003	0.00147	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.0003	0.00147	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000298	0.00146	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000297	0.00146	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000294	0.00144	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000288	0.00141	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000288	0.00141	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000285	0.0014	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000284	0.00139	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—RAF1—dilated cardiomyopathy	0.000283	0.00139	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000283	0.00139	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000283	0.00139	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000279	0.00137	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000275	0.00135	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000271	0.00133	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00027	0.00132	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000263	0.00129	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000259	0.00127	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000259	0.00127	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000254	0.00125	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000254	0.00124	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000251	0.00123	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000251	0.00123	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00025	0.00123	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000246	0.00121	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000241	0.00118	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000241	0.00118	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000235	0.00115	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000234	0.00115	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00023	0.00113	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000228	0.00112	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000228	0.00112	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000226	0.00111	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000223	0.00109	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000219	0.00107	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000217	0.00107	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000212	0.00104	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000206	0.00101	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000205	0.00101	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000204	0.000998	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000199	0.000977	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000193	0.000948	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000191	0.000936	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000187	0.000917	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000187	0.000916	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000183	0.000899	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000182	0.000894	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000181	0.000886	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000181	0.000886	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00018	0.000881	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000179	0.000875	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000177	0.000869	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000177	0.000868	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000177	0.000868	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000176	0.000862	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000175	0.000861	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000173	0.00085	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00017	0.000832	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000168	0.000824	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000166	0.000816	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000166	0.000812	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000165	0.000807	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000163	0.000798	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000162	0.000795	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00016	0.000785	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000159	0.000781	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000159	0.000779	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AGT—dilated cardiomyopathy	0.000153	0.00075	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000152	0.000745	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000142	0.000698	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000139	0.000682	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000136	0.000667	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000136	0.000667	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000135	0.000661	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000135	0.000661	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000132	0.000647	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000129	0.000634	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000129	0.000633	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000125	0.000615	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000123	0.000606	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000123	0.000604	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000121	0.000595	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GPX1—dilated cardiomyopathy	0.000117	0.000574	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000115	0.000563	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CD36—dilated cardiomyopathy	0.000114	0.000559	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000113	0.000556	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000112	0.000552	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000111	0.000544	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000106	0.000521	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000104	0.000508	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AGT—dilated cardiomyopathy	0.000103	0.000503	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000102	0.000502	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.0001	0.000492	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.83e-05	0.000482	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	9.78e-05	0.00048	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.69e-05	0.000475	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	9.58e-05	0.00047	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.44e-05	0.000463	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.57e-05	0.00042	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.5e-05	0.000417	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.45e-05	0.000414	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.88e-05	0.000386	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.71e-05	0.000378	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	7.63e-05	0.000374	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	7.29e-05	0.000358	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EGFR—dilated cardiomyopathy	7.28e-05	0.000357	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	6.79e-05	0.000333	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	6.65e-05	0.000326	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.88e-05	0.000288	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	5.06e-05	0.000248	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	4.65e-05	0.000228	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	4.56e-05	0.000224	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	4.32e-05	0.000212	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	4.2e-05	0.000206	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	3.79e-05	0.000186	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.47e-05	0.00017	CbGpPWpGaD
